Vibegron not checked
Urovant Sciences GmbH · RVT-901 · MK-4618
FollowEvery change as it happens, and a Monday email
Trials
1 active
6 in total · 1 in the EU
What this is
- How it works
- beta3-Adrenergic Agonist FDA class
- How it’s given
- “Participants will be administered Vibegron orally, once daily (QD)”In the company’s words, NCT05491525 on ClinicalTrials.gov
- Tested for
- Neurogenic Detrusor Overactivity
- Main trialPhase 2/3
- “The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC”In the company’s words, NCT05491525 on ClinicalTrials.gov
- Other names
- RVT-901 · MK-4618 · KRP-114V · URO-901 · KRP114V · MK4618
Coming up1
- Mar 2030Phase 2/3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2/3Recruiting | Mar 2030 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC | |
| Phase 3Completed | 10 Jan 2019 | A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) | |
| Phase 3Completed | 13 Jun 2019 | An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). | |
| Phase 3Completed | 29 Jul 2022 | Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia | |
| Phase 3Completed | 15 Jun 2023 | Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) | |
| Phase 2Completed | 25 Sep 2020 | Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026